Excelsior Biopharma Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 384.908 million compared to TWD 432.321 million a year ago. Operating income was TWD 22.265 million compared to TWD 66.890 million a year ago. Net income was TWD 16.362 million compared to TWD 41.911 million a year ago. Basic earnings per share was TWD 0.35 compared to TWD 0.9 a year ago. For the half year, sales was TWD 753.656 million compared to TWD 849.218 million a year ago. Operating income was TWD 42.093 million compared to TWD 141.789 million a year ago. Net income was TWD 32.414 million compared to TWD 105.766 million a year ago. Basic earnings per share was TWD 0.69 compared to TWD 2.27 a year ago. Diluted earnings per share was TWD 0.69 compared to TWD 2.26 a year ago.